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Therapy with hyperthermal chemotherapy in pleural diﬀuse malignant mesothelioma had limited beneﬁts for patients. Here
we investigated the eﬀect of heat stress on heat shock proteins (HSP), which rescue tumour cells from apoptosis. In human
mesothelioma and mesothelial cells heat stress (39–42
◦C) induced the phosphorylation of two mitogen activated kinases (MAPK)
Erk1/2 and p38, and increased Hsp40, and Hsp70 expression. Mesothelioma cells expressed more Hsp40 and were less sensitive
to heat stress compared to mesothelial cells. Inhibition of Erk1/2 MAPK by PD98059 or by Erk1 siRNA down-regulated heat
stress-induced Hsp40 and Hsp70 expression and reduced mesothelioma cell survival. Inhibition of p38MAPK by SB203580 or
siRNA reduced Hsp40, but not Hsp70, expression and also increased mesothelioma cell death. Thus hyperthermia combined with
suppression of p38 MAPK or Hsp40 may represent a novel approach to improve mesothelioma therapy.
Copyright © 2009 Michael Roth et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Pleural Diﬀuse Malignant Mesothelioma (PDMM) is mainly
induced by inhalation of asbestos crystals, or to a lesser
extent by SV40 infection [1]. It was predicted that the
cases of mesothelioma will decline after 2010, but recent
studies indicated the persistence of new PDMM patients
at a high level for another 10–15 years in Europe and
in the USA; in other countries the rate may even further
increase [1]. Unfortunately most PDMM cases are diagnosed
at advanced stages and then PDMM are highly resistant to
chemotherapeutic agents [1]. Locally applied heated (hyper-
thermal) chemotherapy had been suggested to improve the
drug’s eﬀect on PDMM, but the expectations had been
disappointing in most studies reporting only short term
beneﬁts for the patients [2–5]. Moreover, the eﬀect of heat
stress by itself had not been studied in detail in PDMM.
Normal mesothelial cells enable the pleural sheets of the
rib cage and the lung to move freely. This function is hin-
dered by asbestos ﬁbres which induce a local inﬂammation
of the pleura which is linked to the activation of intra cellular
signalling proteins such as mitogen activated protein kinases
(MAPK) and subsequent transcription factors. Asbestos
especially, amphiboles and crionite induce, the malignant
transformation of mesothelial cells by a mechanism that
leads to a constitutive activation of intracellular signal
transduction regulatorsincluding diﬀerentMAPK andadhe-
sion molecules [6, 7]. Reactive oxygen radicals, induced
by asbestos not only activates signal transduction, but also
damages DNA [8] and together with continuous, incomplete
wound repair in mesothelial cells may result in malignant
transformation [9, 10]. The observation that mesothelial cell
proliferationiscontrolledbyintracellularsignallingproteins,
mainly the MAPK Erk1/2 and p38 is of interest as both
are activated by asbestos and by oxidative stress [11–15].
Furthermore, asbestos constitutively activates p38 MAPK in
PDMM cells [14–16], however, the underlying mechanism
and its contribution to PDMM cell proliferation is unclear.
Stress, including heat (hyperthermia), also induces intra-
cellular signalling via Erk1/2 and p38 MAPK which may2 Journal of Biomedicine and Biotechnology
lead to either cell death or survival [17–19]. These two
signalling pathways can stimulate the expression of heat-
shock-proteins (Hsp), Hsp27, Hsp40, and Hsp70 which can
rescue tumour cells from cell death [19–23]. Hsp70 increases
the resistance of PDMM cells to chemotherapeutic drugs
[24]. Intracellular Hsp has been implicated in the protection
of tumour cells from apoptosis of other tumour types it is
implicated that intracellular Hsp protects tumour cells from
apoptosis, while secreted Hsp stimulate the immune system
to attack tumour cells [25–29]. Thus the question is if Hsp
activation has a beneﬁcial or worsening eﬀect in PDMM
therapy. Therefore, we investigated the eﬀect of heat stress
on MAPK, and Hsp expression in PDMM cells as well as the
eﬀect of both factors on the cell’s survival.
2.MaterialandMethods
Cell Culture. Three human PDMM cell lines (NO36, STY51,
ONE58,) were cultured and passaged as previously described
[16]. One SV40 immortalised mesothelial cell line Met5 was
used as control and cultivated as described earlier [15].
Heat Stress. Cells were seeded (1 × 104 cells/cm2)i nR P M I
1640 (Invitrogen, Mount Waverley, Vic., Australia) supple-
mented with 5% fetal bovine serum (FBS) (JRH Biosciences,
Inc., Lenexa, Kansas) in 12-well plates (Falcon Becton
Dickinson, North Ryde, NSW, Australia) for 48–72 hours.
The medium was then replaced with starving medium
(RPMI 1640, 0.2% FBS) for 24 hours, and then the cells were
exposed to heat by placing the cell culture plates in a water
bath for 0, 5, 10, 20 or 30 minutes at increasing temperature
(37, 38, 39, 40, 41, 42◦C). After heat stress, cells were placed
into a 37◦C, 5% CO2incubator at 100% humidity for 0, 0.5,
1 ,3a n d2 4h o u r so r3d a y s .
Proliferation. Proliferation was determined by manual cell
counts on the 3rd day after heat treatment using a Neubauer
slide by standard procedures.
MAPK Function. For MAP kinase experiments, cells were
pretreated for 1 hour with Erk1/2 MAP kinase inhibitor
PD98059 (10μM), or p38 MAP kinase inhibitor SB203580
(10μM) (Calbiochem-Novabiochem Corp., Kilsyth, Vic.,
Australia). Alternatively, Erk1, and p38MAPK were down
regulated for 24 hours by incubation with respective small
inhibitory RNAs (siRNA) [catalogue number (cat num-
ber) SI00042462, cat number SI00025263, Qiagen, Hom-
brechtikon, Switzerland] or with siRNA for Hsp40 and
Hsp70 (Qiagen), the ﬁnal concentration of siRNA was 5 nM.
Cell Survival. Cell Survival was assessed by trypan-blue
exclusion staining and by the expression of caspase-3 using
a commercially available ELISA kit (R&D System, Inc,
Minneapolis, MN, cat number KM300).
Protein Extraction. Total protein was dissolved in Laemmli
buﬀer as described earlier (16, 30). Nuclear and cytosalic
proteins were isolated by a NE-PER reagent kit (cat number
23235, Pierce, Thermo Scientiﬁc, Lausanne, Switzerland) as
described by the distributor.
Immuno-Blotting. Total all protein (10μg) was denatured
(95◦C, 5 minutes), chilled on ice (5 minutes), centrifuged
(13,000 × g, 50 seconds), and applied to electrophoresis
(4%–15% SDS-PAGE). Proteins were transferred onto two
sandwiched PVDF membranes by over night transfer at
50◦C( b u ﬀer), which was conﬁrmed by staining of one
membrane with Coomasie Blue, the 2nd membrane was
washed three times with PBS, blocked with 5% skimmed
milk in PBS (4◦C, overnight), and incubated with one of
the primary antibodies (CellSignal Technol. Inc, Danvers,
MA: Cat number 9212: p38 MAPK; phos-p38: number
9215; Erk1/2: number 9122; phos-Erk1/2 : number 4377;
Hsp40: number 4868, Hsp70: number 4876) for 1 hour
at room temperature. Unbound antibodies were washed
and membranes were incubated with horseradish-labelled
species-speciﬁc secondary antibodies for 1 hour (room tem-
perature). After washing (3 × 15 minutes) the membranes
with blocking buﬀer bound antibody signals were detected
by ECL substrate and documented on X-ray ﬁlm [30].
Statistical Analysis. All data were analyzed by ANOVA and
Fischer PLSD test, unless stated otherwise.
3. Results
Compared to the cell numbers at the day of seeding (10,000
cells/cm2) cell counts increased by 60% over 3 days in
both mesothelial and PDMM cells and heat stress (41◦C, 10
minutes) signiﬁcantly reduced proliferation in PDMM cells
after 3 days (student’s t-test, paired, two-tailed: P<. 01)
(Figure 1(a)). Interestingly non-malignant mesothelial cells
were signiﬁcantly more sensitive to increasing temperature
compared to PDMM cells. In mesothelial cells kept at
37◦C, a temperature increase to >39◦Cf o r2 0m i n u t e s
signiﬁcantly reduced cell proliferation (P<. 01, Figure 1(b)).
In both cell types the inhibition of proliferation correlated
inversely with temperature increase and duration of heat
stress (Figure 1(b)).
As we reported earlier p38 MAPK was constitutively
activated in PDMM cells [15] and heat stress did not modify
this eﬀect (Figure 2(a)). In contrast in mesothelial cells tem-
peratures higher than 40◦C activated the phosphorylation of
p38MAPK within 10 minutes, while the content of total p38
MAPK was not altered (Figure 2(b)).
A low level of active Erk1/2 MAPK was detected in the
nuclear protein fraction of cells grown at 37◦C, and heat
stress increased the level of total Erk1/2 MAPK and signif-
icantly stimulated the phosphorylation of Erk1/2 MAPK in
thenuclearprotein fraction(Figure 2(c)). Whentreatedwith
temperatures >40◦C the accumulation of phosphorylated
Erk1/2 MAPK increased within 10 minutes and decline
after 30 minutes (Figure 2(c)). We observed no diﬀerences
for Erk1/2 MAPK phosphorylation comparing PDMM to
mesothelial cells (data not shown).Journal of Biomedicine and Biotechnology 3
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Figure 1: Heat stress induced cell death in (a) mesothelioma
cell lines (n = 3) and (b) one mesothelial cell line. Viability
was determined by manual cell counting of trypan blue exclusion
stained cells 3 days after heat stress. ∗ indicates P<. 01 compared
to cells at 37◦C. Each data point represents the mean ± S.E.M.of
three independent experiments in each cell line.
At 37◦C Hsp 40 and Hsp 70 were expressed at
low levels by mesothelial cells (Figure 3(a)) and PDMM
cells (Figure 3(b)). In mesothelial cells heat stress above
40◦C increased the expression of Hsp70 within 24 hours
(Figure 3(a)),whileHsp40wasalreadyexpressedat37oCand
declined 6 hours after heat stress (40◦C, 20 minutes), and
increased to the initial level after 48 hours (Figure 3(a)). In
PDMMcellsheatstress(40◦C,20minutes)stimulatedHsp70
expression at 6 hours with a further increase until 48 hours
(Figure 3(b)). In contrast to mesothelial cells in PDMM cells
also Hsp40 was strongly upregulated by heat stress (40◦C, 20
minutes) at 24 and 48 hours (Figure 3(b)).
When PDMM cells were pre-treated for 1 hour with
either a chemical inhibitor for Erk1/2 (PD98059, 10μM)
or for 24 hours with Erk1 MAPK siRNA, we observed
an incomplete reduction of Hsp70 and a total decrease
of Hsp40 (Figure 3(c)). The suppression of p38 MAPK by
either a chemical inhibitor (SB203580, 10μM) or by p38
MAPK siRNA downregulated the heat-induced (40◦C, 20
minutes) expression of Hsp70 and reduced that of Hsp40
to a lesser degree in PDMM cells (Figure 3(d)). The down-
regulation of p38 and Erk1/2 MAPK had similar eﬀects on
heat-induced Hsp40 and Hsp70 expression in mesothelial
cells (data not shown). In Figure 3(e) we provide proof that
pretreatment with either the chemical inhibitors or with the
respective siRNAs (24 hours) speciﬁcally down-regulated the
expression and phosphorylation of Erk1 and p38 MAPK in
PDMM cells.
The suppression of Erk1/2 MAPK signiﬁcantly reduced
proliferation of mesothelial and PDMM cells under normal
conditions (10% FCS, 37◦C) (Figure 4(a)). When pre-
treated (1 hour) with p38 MAPK siRNA (10nM) only
the proliferation of PDMM cells was signiﬁcantly reduced
at 37◦C, while that of mesothelial cells was not aﬀected
(Figure 4(b)). Pre-treatment with either p38 or Erk1 MAPK
siRNA increased the heat sensitivity of PDMM cells, which
was reﬂected in signiﬁcantly reduced cell counts after 3
days (Figure 4(b)). Interestingly, the survival of heat stress
in mesothelial cells was not further reduced by p38 MAPK
inhibition (Figure 4(a)), but was completely abrogated by
inhibition of Erk1/2 MAPK (Figure 4(b)).
In PDMM cells, down-regulation of Hsp40 by speciﬁc
siRNA did not aﬀect the basic proliferation rate, but
signiﬁcantly increased the cell’s sensitivity to heat stress,
with a maximal reduced proliferation after a 20 minutes
exposure to temperatures >40◦C( Figure 5(a)). Similarly, the
down-regulation of Hsp70 by siRNA did not alter the basic
proliferation of PDMM cells, but also increased the cell’s
sensitivity to heat stress, however, with a much lower eﬀect
comparedtoHsp40inhibition(Figure 5(b)).Formesothelial
cellstheinhibitionofHsp40alsoincreasedtheirsensitivityto
heat(Figure 5(a)),butinhibitionofHsp70hadnoeﬀectatall
(Figure 5(b)).
Wealsoassessedthesynthesisofcaspase-3asanindicator
for apoptosis in heat stressed cells but observed only a
relative small increase of caspase-3 levels by PDMM cells
which did not correlate with the increase of the temperature
(Figure 5(c)).
4. Discussion
This study provides evidence that mesothelial cells produce
less Hsp40 than PDMM cells and are therefore, more
sensitive to heat stress than PDMM cells. PDMM cells escape4 Journal of Biomedicine and Biotechnology
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Figure 2: Heat stress activates phosphorylation of Erk1/2 and p38 MAPK. (a) Representative immunoblot of p38 MAPK phosphorylation
and nuclear accumulation by heat stress (40◦C, 20 minutes) in mesothelial cells. Similar results were obtained in two additional experiments.
Coomasie blue was used to control equal protein loading (loading control). (b) representative immunoblot of constitutive p38 MAPK
phosphorylation in PDMM cells (LO68). Similar results were obtained in the other two PDMM cell lines. (c) representative immunoblot of
Erk1/2 phosphorylation and nuclear accumulation after heat stress (40◦C, 20 minutes) in PDMM cells (LO68). Similar results were obtained
with two other PDMM cell lines and in mesothelial cells.
hyperthermia by expressing both Hsp40 and Hsp70 via the
activationofErk1/2andp38MAPK.Theconstitutivelyactive
p38 MAPK by PDMM cells was essential for the expression
ofHsp40andHsp70,whileErk1/2MAPKseemedtoplayless
important role. Importantly, the down-regulation of either
Hsp40 or Hsp70 or p38MAPK increased the heat sensitivity
of PDMM cells.
Several studies indicated that the malignant transfor-
mation of mesothelial cells is linked to a modiﬁcation of
p38 MAPK activity and its interaction with Erk1/2 MAPK
on a yet to be deﬁned level, which is essential for the
malignanttransformation[12–15].TheinteractionofErk1/2
with p38MAPK is necessary to prevent cells from entering
apoptosis [26]. This report is in line with our observation of
constitutively activated p38 MAPK [16] and low expression
of caspase-3 in PDMM cells also after heat exposure. It had
beensuggestedbyanotherstudythatcaspase-3expressionby
PDMM cells correlated with resistance to apoptotic stimuli
[31].
Increase expression of Hsp70 correlated with low levels
of the cell cycle inhibiting protein p21(Waf1/Cip1) which
would mediated apoptosis in ovarian and PDMM cells [24].
However, in most cell types, including tumour cells, the anti-
apoptotic eﬀect of Hsp70 depends on its interaction with
Hsp40 [26, 32–35].
The function of Hsp is that of chaperons which rescue
and re-constitute the folding of proteins if they have been
misfolded by various stress factors, such as oxygen radicals
or heat [33–36]. Hsp40 especially inhibited the action of
proteasomes which, when activated, degrade a wide varietyJournal of Biomedicine and Biotechnology 5
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Figure 3: Heat stress induces Hsp expression. Representative immunoblots of of Hsp70 and Hsp40 expression after heat stress (40◦C, 20
minutes) by (a) mesothelial cells and (b) PDMM cells (LO68). (c) Erk1/2 MAPK mediated the heat stress-induced (40◦C, 20 minutes)
expression of Hsp70 and Hsp40 by PDMM cells (LO68). (d) p38 MAPK mediated heat stress-induced (40◦C, 20 minutes) expression of
Hsp40 and Hsp70 expressions in PDMM cells (LO68). Similar results were obtained in the two other PDMM cell lines and in mesothelial
cells. (e) Speciﬁc protein suppression by siRNAs for Erk1 or p38 MAPK in PDMM cells (LO68). Coomasie blue was used to control equal
protein loading (loading control).
of proteins leading to cell death [34]. Thus Hsp are an
important highly conserved protein family that is essential
for the survival of all cell types under stress conditions [32].
In line with other studies our data indicated that Hsp70
alone is a weak inhibitor of heat induced cell death, while
the inhibition of Hsp40 signiﬁcantly increased PDMM cell’s
sensitivity to heat stress.
In our study, heat stress increased Hsp70 expression
via the preceding activation of the signal transducer Erk1/2
MAPK. These results are in line with studies in diﬀerent
tumour types and indicate an oxygen sensing mechanism
for Erk1/2 and p38 MAPK [18–23]. However, the induction
of Hsp40 by heat via the activation of Erk1/2 MAPK had
only been indicated indirectly in T-cells [37, 38]. In regard
to PDMM asbestos ﬁbres cause oxygen radical formation
[14,15]andwhichErk1/2MAPKactivity[11,12]ma yprime
PDMM cells to survive heat stress or increase their resistance
to chemotherapy. Taking into account that down-regulation6 Journal of Biomedicine and Biotechnology
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Figure 4: The role of Erk1/2 and p38 MAPK in heat stress-induced cell death in PDMM and mesothelial cells. (a) Cell were pre-incubated
with 5 or 10nM of Erk1 MAPK small inhibitory (si)RNA and then exposed to various temperatures (39–42◦C) for 20 minutes. Following
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preincubated with 5 or 10nM of p38 MAPK siRNA as described above (a) and viable cells were counted after trypan blue exclusion staining.
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Figure 5: Hsp40/70 rescue cells from heat stress. (a) Cells were pre-incubated with 5 or 10nM of Hsp40 siRNA and then exposed to
increasing heat stress (39–42◦C) for 20 minutes. Following cells were kept under normal growth conditions for 48 hours and viable cells
were counted after trypan blue exclusion staining. (b) Cells were pre-incubated with 5 or 10nM of Hsp70 siRNA and treated as described
above “a”. Data points represent the mean ± S.E.M. of triplicate experiments. ∗ indicates P<. 01 compared to control (student’s paired t-
test,two-tailed).(c)Expressionofcaspase-3byPDMMtreatedforvarioustimeintervalswithincreasingtemperatures.Datapointsrepresent
the mean ± S.E.M. of triplicate experiments.
of either Erk1/2 or Hsp40 most eﬀectively disrupted the
rescue of PDMM cells from heat stress-induced cell death
implicates its important role in the rescue and survival.
However, as Erk1/2 MAPK was also the most important
mediator of growth for mesothelial cells and its suppression
killed most cells. Therefore, we suggest that the inhibition of
Hsp40 would be the best option to increase heat sensitivity
of PDMM cells.
The induction of Hsp70 via p38 MAPK had been
described in other cell types, including human asterocytes,
cardiac cells, ﬁbroblasts, head and neck cancer cells [18–
24]. However in PDMM cells, p38 MAPK was constitutively
activated [13–16] and needed the interaction with Erk1/2
MAPK to increase Hsp expression. This constitutively active
p38 MAPK together with Erk1/2 MAPK are central for
PDMM cell proliferation. Compared to other studies, our
data implies that p38 MAPK is controlling Hsp70 expression
in PDMM by a diﬀerent mechanism more than in non-
transformed cells [18–23, 39]. This might indicate a cell type
speciﬁc eﬀect or a special modiﬁcation of signalling linked
to the transformation of mesothelial cells. In contrast to
other tumour types a central role of Hsp70 in heat stress
survivalisindicatedforPDMM [32, 39]. Thus,weconclude
that it might be more eﬀective to suppress both Hsp40 and
Hsp70 to sensitize PDMM cells to heat; however, under the
condition of this study we did not observe any synergistic
eﬀect.
In summary, our data suggest that PDMM cells respond
to heat stress with an increased production of the stress
proteins Hsp40 and Hsp70 that rescue them from death.
Therefore the inhibition of Hsp40/Hsp70 or Erk1/2 MAPK
might present a new option to increase the success of
hyperthermia in mesothelioma.
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